Free Essay

Biopharmaceuticals

In:

Submitted By KlutchCity
Words 463
Pages 2
1. Why are drugs classified in the categories they are?
Drugs are classified by the area the drug effects or its particular effect on the body. For example, if an individual has a headache they typically use one of two things, either a non-steroid anti-inflammatory drug (NSAID) or a vasodilator. Ibuprofen is a NSAID and is used to treat inflammation, which could be a cause of a headache. Aspirin, however, is a vasodilator and is used to open the blood vessels to allow more blood and oxygen to get to the brain. 2. Give a description of the actions of drugs in each category.
Cardiac Medications – These drugs are used to stabilize the heartbeat or used to lower and control high blood pressure.
Anticoagulant, Antiplatelet, and Thrombolytic Medications – These drugs are used to thin the blood apart to break up and prevent blood clots.
Analgesic Medications – These drugs are used as pain relievers and most are over-the-counter drugs.
Antihistamines and Endocrine Medications – Antihistamines are used to block the immune system response in allergic reactions, such as hives and swelling. Endocrine drugs include insulin, which lowers blood sugar, or glucagon, which raises blood sugar.
CNS Medications – These medications are used to control problems with the brain, generally mental health issues such as anxiety, depression, or other mental disorders.
Anti-Infective Agents – These medications are known as antibiotics, which are used to fight infections caused by bacteria. Viruses cannot be combated with these drugs. 3. What is chemotherapy and which diseases are treated this way?
The textbook definition of chemotherapy is a combination of two or more drugs used to combat a disease, usually used to treat cancer patients. Chemotherapy destroys cancer cells by using a combination of drugs that are toxic to the cancer cells of the specific type of cancer the patient has. Chemotherapy is very potent and can even be harmful to the professional administering the drugs. 4. Give examples of how contrast media are used to produce an image.
Contrast medias are used to light up specific organs while a particular scan is being done, whether it be a CT, MRI, etc. An image is produced on a radiograph when the content of iodine in the patient’s blood prevents the penetration of the photons emitted by x-rays. Typically, iodine is the main component of contrasting medias. 5. Compare ionic and non-ionic contrast media.
Ionic contrast media uses iodine to essentially highlight organs or organ systems in the body by iodine attaching itself to the water molecules in the body, thus producing positive cations. Non-ionic means that no positive cations are produced, therefore the balance of blood plasma is not disrupted because the immune system does not recognize it as a foreign matter.

Similar Documents

Free Essay

Ipr in Biotechnology Transfer

...IPR plays a very vital role in protecting Biotechnology transfer rights and provide the proper mechanism for the sustainable use of its components as well as the fair and equitable sharing of the benefits arising out of the use of biodiversity. Basically, the Biotechnology defined as “any technological application,” applies to products, not procedures. In furtherance to that, the pharmaceutical industry developing immeasurably in the field of biotechnology and IPR is the only instrument which can protect the foremost rights arising out of transferring the Biotechnology. As I mentioned earlier that technology is the application of knowledge to solving specific problems or unpretentious meeting identified needs. In respect to the aforementioned topic, biotechnology transfer appreciates as ‘the technology transfer in which the application of technologies in new geographic or product areas, generally involving adaptation to local needs and conditions.’ According to the Convention on Biological Diversity, the convention intently giving special attention and it is only because of its specific references within the Convention. Biotechnology, defined therein as “any technological application,” applies to products, not procedures. Due to the diversity of product traits, biotechnology cannot be treated as a single entity, but rather must be addressed as a composite of products with individual specific attributes and transfer processes. Technology transfer activities that are based on...

Words: 569 - Pages: 3

Premium Essay

Biocon

...|Biocon | Consolidated Financial Performance: | |(Rs. In Crores) | |  |2005 |2006 |2007 |2008 |2009 |2010 | |Sales | |Bio Pharmaceuticals |557 |603 |728 |787 |1372 |2036 | |Enzymes |90 |85 |95 |46 |- |- | |Research and Technical Licensing Fees |66 |100 |163 |220 |237 |332 | |  | |Total |713 |788 |986 |1054 |1609 |2368 | |  | |Other Income |15 |5 |4 ...

Words: 2907 - Pages: 12

Premium Essay

Accounts

...Rules of Thumb for Chemical Engineers. Edition No. 5 Description: The most complete guide of its kind, this is the favored handbook for chemical and process engineers who need a reliable and authoritative solution to their practical on the job problems. Includes all new material on new processing sectors, include biopharmaceuticals. The text is comprehensively revised and updated with new data and formulas. Rules of Thumb for Chemical Engineers solves process design problems quickly, accurately and safely, with hundreds of common sense techniques, shortcuts and calculations. Key features; - Rules of Thumb for Chemical Engineers brings together solutions, information and work-arounds that engineers in the process industry need to get their job done. - New material in the Fifth Edition includes physical properties for proprietary materials, six new chapters, including pharmaceutical, biopharmaceutical sector heuristics, process design with simulation software, and guidelines for hazardous materials and processes. - Now includes SI units throughout alongside imperial, and now accompanied by online calculation tools New to this edition; - New chapter on biopharmaceutical systems - New chapter on closed-loop heat transfer systems - Extensively rewritten chapters on fluid flow, fractionation, heat exchangers, pumps, compressors, safety, and controls. - Latest information on packed columns and structured packings - Excel workbooks, with Visual Basic for Applications function subroutines...

Words: 754 - Pages: 4

Premium Essay

Biomab

...the start of a biorevolution in India. Over the years, Biocon has evolved from an enzyme-manufacturing company into a fully integrated biopharmaceutical enterprise. Today, we leverage a formidable combination of proprietary fermentation technologies and research skills to develop affordable therapy for unmet medical needs 

Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw 

1979

Biocon is the first Indian company to manufacture and export enzymes to USA and Europe 

1989

Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with its subsidiary, Quest International 

Biocon is the first Indian biotech company to receive US funding for proprietary technologies 

1990

Biocon scales up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level 

1993

Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany 

1994

Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector

1996

The commercial success of Biocon's proprietary fermentation plant leads to a 3-fold expansion 

Biocon leverages its technology platform to enter biopharmaceuticals and statins 

1997

Biocon spearheads initiatives in human healthcare through a dedicated manufacturing facility 

1998

Unilever inks...

Words: 1246 - Pages: 5

Premium Essay

Marketing Strategies

...MANAGING STRATEGY OF JOHNSON & JOHNSON I. INTRODUCTION TO STRATEGY Strategy is a long-term and future-oriented plan which interacts in the competitive environment in order to achieve company goals. (Thomson, 2003) Picture 1: Three levels of Strategy Source: Created by author An organisation contains three-levels of strategy. The top hierarchy refers the corporate-level strategies that attempts to make use of the firm’s unique competencies by accepting a portfolio to the business management by developing long term plans. And the middle is the decision-making hierarchy at business-level that translates the statement’s direction and generates corporate-level strategies for business units or SBUs. And the bottom hierarchy is functional-level that develops short term strategies and annual objectives in different areas of organisation. (David, 2003) II. ORGANIZATION & BUSINESS SEGMENTS Company Profile Johnson & Johnson- A most comprehensive health-care firms in the world and most diversified. J&J manufactures health care products for consumer & personal care, pharmaceutical, medical devices and diagnostics markets. It is operating its firms in 57 countries and nearly 200 companies around the world. J&J generates nearly half of its revenues from outside US; through its operating networks and marketing organizations that sells products in 175 countries. (Web 1) Key Facts- Johnson & Johnson Incorporated | 1887, Public Company | Employees...

Words: 3826 - Pages: 16

Free Essay

Core Functions of Fda

...Thesis: One of the biggest agencies within the U.S. Department of Health and Human Services is the Food and Drug Administration (FDA). The Office of the Commissioner and four directorates administer the core functions of the agency which are medical products and tobacco, foods and veterinary medicine, global regulatory operations and policy, and operations. While being a huge, big named agency designed to protect and provide public health; there are necessary regulations and guidelines to ensure the purpose of the agency is being met. This paper will explore the needs, stakeholders, expected outcomes, and other regulatory action and implementation of the FDA. Introduction: The Food and Drug Administration Safety and Innovation Act (FDASIA) is a regulation which was proposed by The Food and Drug Administration (FDA or Agency) to establish a list of “qualifying pathogens” that are likely to cause serious harm to public health. FDASIA utilizes the agency’s ability to protect and improve public health by giving the authority to collect user fees, promoting innovation, increasing stakeholder involvement, and enhancing the safety of the drug supply chain. Methicillin-Resistant Staphylococcus aureus (MRSA) is a “staph” germ that does not improve with the first-line antibiotics that typically cure staph infections. When this takes place, the germ is “resistant” to the antibiotic. This class of antibiotics includes penicillin, amoxicillin, oxacillin, methicillin, and others. (MRSA...

Words: 2680 - Pages: 11

Premium Essay

Pfizer Overview 2012

...| Pfizer | Memo To: Professor Fear From: Alexander Ouji Date: [ 1/30/2012 ] Re: Pfizer Overview Pfizer is the largest pharmaceutical company in the world.  Upon reviewing annual reviews and financial reports from the past 5 years, Pfizer, although dealing with many issues both inherent and external, is keeping a stable financial condition as well as keeping its strategic operations aligned with its goals and objectives.  The following is an overview which will further explain the company’s management and financial climate.   Strategy   Pfizer’s broad goal is to apply science and global resources to improve health and well-being at every stage of life.[1]  Their strategy has been to essentially “beat their competitors to the punch” by being the first to develop and market pharmaceutical drugs.  They do this by investing heavily in research and development. In the past six years, their average research and development expense has been 8 billion dollars, with 2010 being the highest amount at 9.4 billion.[2]  They have continued to spend approximately this amount despite continued efforts to reduce costs in certain parts of their research dealing mainly with diseases including cardiovascular.  With such large sums of money being invested in research and development, the huge risks involved highlights the confidence they have in their talent in terms of successfully developing new, brand pharmaceutical drugs.    Pfizer is constantly looking to diversify its portfolio...

Words: 1871 - Pages: 8

Premium Essay

Global Bussiness

...used to analyse and monitor the external marketing environment factors that have an impact on a business. Porters five forces states that “the structure of an industry and the ability of firms in that industry to ace strategically depend upon the relative strengths of five forces: current competition, potential competition, the threat of substitute products, the power of buyers and the power of suppliers” Ian Worthington and Chris Britton (2006) By using these tools there will be clear evidence of the strengths, weaknesses, opportunities and threats that a currently effecting the pharmaceutical industry. The different sectors such as conventional, biopharmaceuticals and vaccines have slight differences when using the porters five forces tool, these will also be looked at in the industry life cycle and determined their place Pestle analysis looks at the likely changes in the six factors below and seeks to predict changes that are likely to occur and the consequences this could have for a business. “PESTLE is a mnemonic which in its expanded form denotes P for Political, E for Economic, S for Social, T for Technological, L for Legal and E for Environmental. It gives a bird’s eye view of the whole environment from many different angles that one wants to check and keep a...

Words: 2096 - Pages: 9

Premium Essay

Merck Acquisition of Medco Study and Analysis

...Merck Acquisition of Medco Study and Analysis Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization, liberalization, technological developments, and competitive business environment (Fisher & Siburg, 2009). The synergistic gains from M&A may result from efficient management, economies of scale, profitable use of assets, exploitation of market power, and the use of complementary resources (Mitchell et al, 2004). Theoretically it is assumed that mergers improve the performance of the acquiring firm due to increased market share and synergy impact. This paper reviews the acquisition of Medco Medco Containment Services, Inc. (Medco) by Merck & Company (Merck) and cites reasons for acquisition of Medco. Merck's acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical industry lies (Nichols, 1994). In today's managed-care environment, Vagelos (CEO of Merck in 1993) argues, the company that best controls the information flow from doctor to patient to pharmacist to plan sponsor has the greatest chance of succeeding. Medco has information on 38 million patients, which allows Merck to learn a lot more about how its drugs are prescribed and used and, ultimately, how effective they are in fighting disease. Owning Medco can also help Merck increase its market share in an industry in which no company has more...

Words: 2407 - Pages: 10

Premium Essay

Biocon

...2012 STRATEGIC MANAGEMENT TERM PAPER ALOK KEJARIWAL 1PI11MBA13 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to USA and Europe. 1989—Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with...

Words: 4668 - Pages: 19

Free Essay

Data Quality

...Data quality is a key characteristic that determines the reliability of data for making decisions. We know high quality data is complete, accurate, available, and timely. Business leaders recognize the value of big data and are eager to analyze it to obtain insights and improve their business outcomes. Organizations need to lay a strong foundation for managing data quality with the best quality tools and practices that can be scaled and leveraged across their enterprises. For example, IBM offers “Infosphere Information Server” for data quality which enables data quality that is sustainable overtime because of its ease of use and flexibility. The features of the program increase the awareness of data quality across an organization, raising the priority and ease of maintaining data quality. IBM supports that “Infosphere Information Server” provides a resilient, reliable, high-performance platform for mission-critical data and is also the foundation for successful data quality and governance initiatives. Another example, department of defense (aka military operations), intelligence anaylsis, and logistics are known to have big data applications with data growing at enormous rates and have a need for scalable software solutions to sustain future operations. A couple of examples where the department of defense uses big data are the following: electronic health records and flight data management. For electronic health records workloads can include care delivery, force readiness...

Words: 716 - Pages: 3

Premium Essay

Pfizer-Wyeth

...that it can get back on track. With having to freeze its dividends, hundreds of layoffs, and stock prices falling, it is imperative to convince the stakeholders that Pfizer will come out of this economic dilemma on top. The acquisition with Wyeth will reduce Pfizer’s negative sales outlook; however, there is only one route to delivering profit growth to investors, and that is by buying growth and cutting costs. Pfizer has announced that it expects to create savings of $4 billion by the third year after closing the acquisition. This is in part due to the 15% reduction in Pfizer-Wyeth’s combined workforce. After the merger, Pfizer will operate through a patient-centric business units in two major areas, biopharmaceuticals and diversified businesses. Its biopharmaceutical business units are emerging markets Where as Pfizer currently has one of the largest sales forces in the industry, Wyeth’s antibiotics and specialty drugs will not require a lot of marketing to consumers, and Pfizer may regard that as a big advantage. Another benefit in Pfizer acquiring Wyeth is its strong presence in biotech drugs as Pfizer has had little success in this area of pharmaceuticals. For too long the majority of Pfizer’s drug portfolio has personified the representative Big Pharma product set of small molecule cardiovascular drugs. The merger with Wyeth will bring a positive...

Words: 604 - Pages: 3

Premium Essay

Finanve in Banking

... Section: B Semester : 3rd Batch : 2011-2013 PES Institute of Technology 2012 1/1/2012 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to USA and Europe. 1989—Unilever plc. acquires Biocon Biochemicals Ltd...

Words: 4681 - Pages: 19

Premium Essay

Homework

...At the Intersection of Health, Health Care and Policy Cite this article as: Henry G. Grabowski, Joseph A. DiMasi and Genia Long The Roles Of Patents And Research And Development Incentives In Biopharmaceutical Innovation Health Affairs, 34, no.2 (2015):302-310 doi: 10.1377/hlthaff.2014.1047 The online version of this article, along with updated information and services, is available at: http://content.healthaffairs.org/content/34/2/302.full.html For Reprints, Links & Permissions: http://healthaffairs.org/1340_reprints.php E-mail Alerts : http://content.healthaffairs.org/subscriptions/etoc.dtl To Subscribe: http://content.healthaffairs.org/subscriptions/online.shtml Health Affairs is published monthly by Project HOPE at 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814-6133. Copyright © 2015 by Project HOPE - The People-to-People Health Foundation. As provided by United States copyright law (Title 17, U.S. Code), no part of Health Affairs may be reproduced, displayed, or transmitted in any form or by any means, electronic or mechanical, including photocopying or by information storage or retrieval systems, without prior written permission from the Publisher. All rights reserved. Not for commercial use or unauthorized distribution Downloaded from content.healthaffairs.org by Health Affairs on February 29, 2016 at UNIV OF CALIFORNIA Intellectual Property & Innovation By Henry G. Grabowski, Joseph A. DiMasi, and Genia Long 10.1377/hlthaff...

Words: 7115 - Pages: 29

Premium Essay

Aurora

...Growth Strategies, Innovation, Alliances, and Execution Capella University Introduction Thompson & Strickland (2013) believes that a successful organization’s strategy depends on people, capabilities, structure, and execution. Important as well are growth and innovation (P.. 286), which allows an organization to remain competitive. Growth strategies arise from an organization’s SWOT where clear guidelines identify areas of focus. Achieving this requires innovation and alliances on products and services that will create a competitive advantage. Successfully execution requires a strategic manager who can effectively and successfully drive strategic objectives, then report its performance to the leadership team (Thompson & Strickland, 2013). This paper will examine how Pfizer utilized growth, innovation and execution strategies as well as acquisitions and mergers to become the number one global pharmaceutical company. The organization’s SWOT analysis (Thompson & Strickland, 2013) showed its strength in being innovative, opportunities to create more products, weakness in its dependence on successful products, and threats in generic competition and regulatory laws. The company’s corporate culture, strategic innovative through the top-down leadership approach, a unified tagline “OWN IT!” (Pfizer, 2013), and a strategy map demonstrates that all employees are ultimately responsible for their individual roles to drive success throughout the organization. Additionally, this...

Words: 4579 - Pages: 19